Ipsen (LTS:0MH6) Tax Expense: €134 Mil (TTM As of Dec. 2025)


LTS:0MH6 Ipsen SA LTS:0MH6
94 GF Score
Price €165.50
GF Value €133.79
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Ipsen Tax Expense?

Ipsen LTS:0MH6 -1.78% 94 Tax Expense is €134 Mil as of Dec. 2025. GuruFocus rates LTS:0MH6 with a GF Score™ of 94/100 and a GF Value™ of €133.79 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Ipsen's tax expense for the months ended in Dec. 2025 was €44 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2025 was €134 Mil.


Ipsen  (LTS:0MH6) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Ipsen Tax Expense Related Terms


Ipsen Tax Expense Historical Data

* Premium members only.

The historical data trend for Ipsen's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ipsen Tax Expense Chart

Ipsen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 158.30 112.30 136.20 74.90 133.60

Ipsen Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.20 47.20 27.70 89.50 44.10
LTS:0MH6
94GF Score
Ipsen SA LTS:0MH6
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ipsen Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €134 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of €134 Mil mean?
Ipsen (LTS:0MH6) has a Tax Expense of €134 Mil as of Dec. 2025. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Ipsen and its competitors.
Is Ipsen's Tax Expense too high?
Ipsen's current Tax Expense is €134 Mil. Overall, Ipsen has a GF Score™ of 94/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ipsen's Tax Expense compare to ZTS and UTHR?
Ipsen's Tax Expense of €134 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Drug Manufacturers company?
A good Tax Expense depends on the Drug Manufacturers industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Ipsen and its competitors. Ipsen's current Tax Expense is €134 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ipsen stock overvalued right now?
Based on GuruFocus' analysis, Ipsen (LTS:0MH6) is currently considered Modestly Overvalued. The stock's GF Value™ is €133.79, compared to a current price of €165.50 — trading 23.7% above its estimated fair value. The current Tax Expense is €134 Mil. Ipsen's overall GF Score™ is 94/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For Ipsen (LTS:0MH6), the current Tax Expense is €134 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ipsen (LTS:0MH6) Overvalued in 2026?

Based on GuruFocus' analysis, Ipsen stock appears to be overvalued. The current stock price of €165.50 is trading 23.7% above its estimated GF Value™ of €133.79. GuruFocus considers Ipsen to be Modestly Overvalued.

Key valuation signals for LTS:0MH6:

  • Tax Expense: €134 Mil
  • GF Value™: €133.79 vs. price of €165.50 (23.7% above fair value)
  • GF Score™: 94/100 with 7 warning signs

No single metric tells the full story. See the LTS:0MH6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ipsen Business Description

Address 70 rue Balard, Paris, FRA, 75015
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders, but in February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for only 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 20 drugs in 115 countries.
94GF Score

Get the complete analysis for LTS:0MH6

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€165.50
Price
€133.79
GF Value